Acute pulmonary embolism (PE) is a life-threatening condition in which blood clots block vessels carrying deoxygenated blood ...
The landscape of coronary and pulmonary vascular medicine is undergoing a paradigm shift, fueled by breakthroughs in molecular biology, imaging, and ...
Sweden: A recent large-scale Swedish study published in the British Journal of Dermatology has revealed that individuals with ...
Analysis of Patients from CLEAR Outcomes Receiving No Other Background Lipid Lowering Therapies, Bempedoic Acid Alone Reduced MACE-4 by 14% ...
Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...
Bristol Myers Squibb in collaboration with Johnson & Johnson today announced the decision to stop the Phase 3 Librexia ACS trial evaluating the efficacy and safety of milvexian when added to the ...
Q3 2025 Earnings Call Transcript November 14, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing ...
Nottinghamshire Live on MSN
'Mum, I don't feel safe here', read Sophie's text. Four weeks later she died
“Mum, I don’t feel safe here,” reads a message to her mother, Leisa, from that short time. At the end of Sophie’s three-week ...
Pancreatic cancer, a notorious 'silent killer,' may now reveal early warnings in the legs. Doctors are highlighting leg pain, ...
Experts share advice for junior colleagues before their first case, including basic keys to success and pitfall avoidance, what to watch for when observing a case, and questions to ask and when to ask ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback